Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation Director departure
|
RVL Pharmaceuticals plc (OSMT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/13/2023 |
8-K
| Quarterly results |
09/29/2023 |
8-K
| Other Events Interactive Data |
08/25/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
08/18/2023 |
8-K
| Quarterly results |
08/14/2023 |
8-K
| Quarterly results |
08/02/2023 |
8-K
| Resignation/termination of a director |
06/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
06/02/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
05/11/2023 |
8-K
| Quarterly results |
03/20/2023 |
8-K
| Quarterly results |
03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
01/09/2023 |
8-K
| Quarterly results |
11/10/2022 |
8-K
| Quarterly results |
10/18/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
08/11/2022 |
8-K
| Quarterly results |
08/04/2022 |
8-K
| Quarterly results |
07/07/2022 |
8-K
| Quarterly results |
06/17/2022 |
8-K
| Quarterly results |
05/12/2022 |
8-K
| Quarterly results |
04/11/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/06/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
04/04/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
03/30/2022 |
8-K
| Quarterly results |
01/19/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
01/18/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
11/17/2021 |
8-K
| Regulation FD Disclosure Interactive Data |
11/15/2021 |
8-K
| Quarterly results |
11/10/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/12/2021 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister...
Docs:
|
"UNDERWRITING AGREEMENT",
"ORDINARY SHARE PURCHASE WARRANT OSMOTICA PHARMACEUTICALS PLC Warrant Shares: Initial Exercise Date: October 12, 2021 THIS ORDINARY SHARE PURCHASE WARRANT certifies that, for value received, _______ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. on April 14, 2025 but not thereafter, to subscribe for and purchase from Osmotica Pharmaceuticals plc, an Irish incorporated public limited company , up to ______ Ordinary Shares , provided that, if there is no effective registration statement registering, or the prospectus contained therein is not available for, the issuance of the Warrant Shares to the Holder at any time during the term of this Warra...",
"A&L Goodbody International Financial Services Centre 25-28 North Wall Quay, Dublin 1 D01 H104 T: +353 1 649 2000 DX: 29 Dublin | www.algoodbody.com Dublin Belfast London New York San Francisco Palo Alto Date 12 October 2021 Our ref 01427724 Your ref Osmotica Pharmaceuticals plc 25-28 North Wall Quay Dublin 1 Ireland Re: Osmotica Pharmaceuticals plc",
"PART II" |
|
10/06/2021 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
09/27/2021 |
8-K
| Quarterly results |
09/08/2021 |
8-K
| Quarterly results |
09/08/2021 |
8-K
| Quarterly results |
09/02/2021 |
8-K
| Quarterly results |
|
|
|